Making Good Clinical Practice More Understandable
This eBook dives into GCP’s role in the clinical research ecosystem and how it protects participant rights, safety, and confidentiality.
Unlocking Study Activation: 2023 Study Activation Report
Access the survey report now for current perspectives on study startup activities impacted by rapidly evolving technology and tools.
Using the Portfolio Rationalization Model to Implement and Optimize Your Training Program
Trend Report: 2023 Trends Impacting Clinical Research
This report defines 2023 clinical research trends and provides an outlook for the industry moving forward.
Setting Yourself up for Success During Investigator-initiated Trials
This eBook shares tips and best practices to guide researchers through the investigator-initiated trial process while staying compliant.
Advarra Trend Report: Current State of Trial Opportunity and Selection
Insights into the site selection process and the information sites provide as part of site feasibility questionnaire completion.
The Revolving Door of Research: The Resourceful Way to Run Trials
Examine the current state of industry resources, resourcing implications, and the way we can now think of work: remote, hybrid, or on-site.
Complete Guide to FDA Inspection Readiness
Learn how to prepare for an upcoming FDA inspection, what to expect during the inspection, and steps to take following inspection close.
The Whole Product Approach
Learn how your organization can implement the Whole Product Approach and how Advarra uses this method to help research sites.
Clinical Trial Superheroes
Download this eBook to learn about the individuals who dedicate their talents to give patients an opportunity for healthier and longer lives.
Research Site Perspectives on Sponsor-provided Technology
This report outlines key survey findings, and offers suggestions as we work towards an industry-wide solution
Advarra Trend Report: The Future of Clinical Staff Development Planning
This report is based on surveys and interviews with organizational leaders from top U.S. biotech and pharmaceutical companies.